Results 211 to 220 of about 275,854 (308)
Serum Amyloid A in Guillain-Barré Syndrome: A New Frontier in Biomarker Research. [PDF]
Kim S, Sohn E.
europepmc +1 more source
Tocotrienols: A Review From Source to Therapeutic Applications
Tocotrienols demonstrate superior antioxidant, neuroprotective, and anti‐inflammatory properties compared to conventional vitamin E forms, with promising therapeutic applications across multiple disorders when delivered through optimized systems that enhance their inherently limited bioavailability.
Natalia‐Carolina Londoño +6 more
wiley +1 more source
Elevated Serum Amyloid A2 and A4 in Patients With Guillain-Barré Syndrome. [PDF]
Yao X +6 more
europepmc +1 more source
Genetic Effects on Serum Concentrations of Serum Amyloid A Protein [PDF]
Toshiyuki Yamada
openalex +1 more source
This study highlights the memory‐enhancing effects of walnuts, almonds, and Torreya, with walnuts showing the strongest potential to improve cognitive function and delay brain aging. ABSTRACT This study explored the memory‐enhancing potential of seven commercially available nuts through nutritional profiling, metabolomics, network pharmacology, and ...
Jiamin Chen +10 more
wiley +1 more source
Serum Amyloid A: A Double-Edged Sword in Health and Disease. [PDF]
Ji A, Meredith LW, Shridas P.
europepmc +1 more source
Buck Wheat: Nutritional, Bioactive Characteristics, Health Benefits, and Side Effects
ABSTRACT Micronutrient deficits have resulted from an over‐reliance on a small number of cereal crops for food security. The agricultural sector faces severe sustainability issues due to the rapid growth of the world's population and sudden climatic changes.
Momina Farooq +2 more
wiley +1 more source
Serum amyloid P secreted by bone marrow adipocytes drives skeletal amyloidosis. [PDF]
Kumar S +14 more
europepmc +1 more source
Serum amyloid A as a prognostic biomarker for 30-day mortality in patients with community-acquired pneumonia patients in the emergency department. [PDF]
Kim SY +4 more
europepmc +1 more source

